The Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as education… Read more
The Oncology Institute Inc (TOIIW) - Total Assets
Latest total assets as of September 2025: $163.62 Million USD
Based on the latest financial reports, The Oncology Institute Inc (TOIIW) holds total assets worth $163.62 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
The Oncology Institute Inc - Total Assets Trend (2019–2024)
This chart illustrates how The Oncology Institute Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
The Oncology Institute Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
The Oncology Institute Inc's total assets of $163.62 Million consist of 65.1% current assets and 34.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 28.8% |
| Accounts Receivable | $48.68 Million | 28.2% |
| Inventory | $10.04 Million | 5.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $14.81 Million | 8.6% |
| Goodwill | $7.23 Million | 4.2% |
Asset Composition Trend (2019–2024)
This chart illustrates how The Oncology Institute Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: The Oncology Institute Inc's current assets represent 65.1% of total assets in 2024, an increase from 36.6% in 2019.
- Cash Position: Cash and equivalents constituted 28.8% of total assets in 2024, up from 4.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, a decrease from 59.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 28.2% of total assets.
The Oncology Institute Inc Competitors by Total Assets
Key competitors of The Oncology Institute Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
The Oncology Institute Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - The Oncology Institute Inc generates 2.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - The Oncology Institute Inc is currently not profitable relative to its asset base.
The Oncology Institute Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.68 | 2.49 | 1.04 |
| Quick Ratio | 1.39 | 2.27 | 0.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $44.51 Million | $ 69.67 Million | $ 1.11 Million |
The Oncology Institute Inc - Advanced Valuation Insights
This section examines the relationship between The Oncology Institute Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -17.5% |
| Total Assets | $172.72 Million |
| Market Capitalization | $3.75 Million USD |
Valuation Analysis
Below Book Valuation: The market values The Oncology Institute Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: The Oncology Institute Inc's assets decreased by 17.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for The Oncology Institute Inc (2019–2024)
The table below shows the annual total assets of The Oncology Institute Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $172.72 Million | -17.46% |
| 2023-12-31 | $209.24 Million | -20.04% |
| 2022-12-31 | $261.67 Million | +28.62% |
| 2021-12-31 | $203.44 Million | +209.70% |
| 2020-12-31 | $65.69 Million | +10.36% |
| 2019-12-31 | $59.52 Million | -- |